Evidence map›Paper›PMID 34668569›Full record

Trial reportCancer2022

Cancer health self-efficacy improvement in a randomized controlled trial.

Corinne R Leach, Shawna V Hudson, Michael A Diefenbach, Kara P Wiseman, Amy Sanders, Kisha Coa, Sicha Chantaprasopsuk, Robert L Stephens, Catherine M Alfano

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 4 pooled it
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 4 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Interactive digital tools to support empowerment of people with cancer: a systematic literature review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Strategies to promote the dissemination of psychosocial digital health resources for those affected by cancer: scoping review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  9. Article
  10. Self-efficacy for cancer self-management in the context of COVID-19: a cross-sectional survey study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  11. Article
  12. Article
  13. Review
  14. Degradable FeRSC advances · 2023
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Corinne R LeachAmerican Cancer Society, Atlanta, Georgia.ORCID 0000-0002-5553-5980
Shawna V HudsonRutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey.
Michael A DiefenbachNorthwell Health, Manhasset, New York.
Kara P WisemanNational Cancer Institute, Rockville, Maryland.
Amy SandersICF International, Fairfax, Virginia.
Kisha CoaICF International, Fairfax, Virginia.
Sicha ChantaprasopsukAmerican Cancer Society, Atlanta, Georgia.
Robert L StephensAmerican Cancer Society, Atlanta, Georgia.
Catherine M AlfanoAmerican Cancer Society, Atlanta, Georgia.
American Cancer Society · USICF International (United States) · USNational Cancer Institute · USNorthwell Health · USRutgers, The State University of New Jersey · US

Funding

The integrated Translational Health Research Institute of Virginia (iTHRIV): Using Data to Improve HealthUL1TR003015 · NCATS · UNIVERSITY OF VIRGINIA · PI BROWN, DONALD E, JOHNSTON, KAREN C. · 2019 to 2023
$20.3M
Institutional Career Development CoreKL2TR003016 · NCATS · UNIVERSITY OF VIRGINIA · PI PAPIN, JASON, WORRALL, BRADFORD B · 2019 to 2023
$3.9M
American Cancer SocietyNCATS NIH HHS KL2 TR003016NCATS NIH HHS UL1 TR003015
6 · The paper itself

Abstract

backgroundeHealth interventions can help cancer survivors self-manage their health outside the clinic. Little is known about how best to engage and assist survivors across the age and cancer treatment spectra.

methodsThe American Cancer Society conducted a randomized controlled trial that assessed efficacy of, and engagement with, Springboard Beyond Cancer, an eHealth self-management program for cancer survivors. Intent-to treat analyses assessed effects of intervention engagement for treatment (on-treatment vs completed) overall (n = 176; 88 control, 88 intervention arm) and separately by age (<60 years vs older). Multiple imputation was used to account for participants who were lost to follow-up (n = 41) or missing self-efficacy data (n = 1) at 3 months follow-up.

resultsSelf-efficacy for managing cancer, the primary outcome of this trial, increased significantly within the intervention arm and for those who had completed treatment (Cohen's d = 0.26, 0.31, respectively). Additionally, participants with moderate-to-high engagement in the text and/or web intervention (n = 30) had a significantly greater self-efficacy for managing cancer-related issues compared to the control group (n = 68), with a medium effect size (Cohen's d = 0.44). Self-efficacy did not differ between the intervention and control arm at 3 months post-baseline.

conclusionsStudy results suggest that cancer survivors benefit variably from eHealth tools. To maximize effects of such tools, it is imperative to tailor information to a priori identified survivor subgroups and increase engagement efforts.

Indexed as

Cancer SurvivorsNeoplasmsSelf-ManagementTelemedicineHumansMiddle AgedSelf EfficacySurvivorscancer survivorrandomized controlled trialself-efficacyself-managementtelemedicine

Identifiers

PMID34668569
PMCPMC9930867
OpenAlexW3205825996

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.